Sonova presents innovations at EUHA 2013
"With the introduction of comprehensive solutions from both Phonak and Unitron, Sonova once again demonstrates broad based industry leading innovation ", says Lukas Braunschweiler, CEO of Sonova. "We are excited about the ongoing roll-out of Roger, a new digital wireless communication standard operating at 2.4 GHz which fits perfectly into the group's wireless strategy. Within one year, Phonak, has successfully launched the most complete portfolio of solutions ever on its well-received Quest platform, including related wireless solutions and accessories. The last piece of the puzzle comes with the launch of a broad range of pediatric devices and tools at this year's congress. This is a remarkable achievement. At the same time Unitron is building on the success of the unique Flex product and service concept, which supports the brand's mission to be a service leader in the industry".
By expanding its range of Roger products, Phonak is offering users with severe to profound hearing loss an extra performance boost in the most difficult listening situations. With Roger, the new digital standard operating at 2.4 GHz, the speaker's voice is directly transmitted into the user's hearing aids. The range of solutions includes the compact and easy-to-use wireless Roger Clip-On Mic and the inconspicuous Roger Pen with fully automated microphone settings and Bluetooth cell phone connectivity. The expanded Phonak Wireless Communication Portfolio also features the new Phonak DECT CP1 cordless phone, which transmits the conversation simultaneously to both hearing aids and can also be used by the whole family.
Based on 40 years of experience in pediatric audiology and in close collaboration with pediatric fitters worldwide, Phonak has developed the most complete portfolio of pediatric solutions ever. It includes Phonak Sky Q, an expanded range of wireless accessories with the new Roger technology and the significantly improved fitting software Junior mode within Phonak Target. The portfolio of solutions has been designed to meet specifically the needs of children.
The Phonak Baseo Q-15 and Tao Q-15 models bring the proven Quest technology to cost-conscious clients for the first time, ensuring great sound and an easy fit. All models offer an outstanding first fit acceptance and can be fit with the Phonak Target software, allowing hearing care professionals to use one software for all their fitting needs. The Baseo Q-15 and Tao Q-15 models offer a perfect balance between performance and affordability, making them the most competitive offering in this performance class.
On October 1, 2013 Unitron announced the next generation of its popular Moxi and Quantum hearing instruments built on the Era platform. Available at four technology levels, the Moxi2 and Quantum2 product families incorporate signature technologies that deliver the ease of listening and clarity of speech necessary to create a best first fit experience and overall increased patient satisfaction. In addition, the product families are available in fresh new styles including the new robust Moxi2 Dura as well as a new BTE.
Moxi2 and Quantum2 are also available with Flex:trial, the industry's first flexible and risk-free hearing trial solution aimed at improving patient satisfaction and hearing instrument adoption. With Flex:trial, patients can be fit the same day with a trial instrument at the recommended technology level, at no cost or obligation, allowing them to experience the benefits of hearing instruments in their daily lives. Highly successful since its introduction to market a year ago, Flex:trial provides hearing care professionals with an unprecedented ability to meet patient expectations while enhancing their business.
Following regulatory approvals in Europe, Canada and the United States earlier this year, Advanced Bionics will showcase Naída CI Q70 (Naída CI), the world's most advanced behind-the-ear sound processor for cochlear implants. Naída CI clearly demonstrates the combined R&D strengths of Advanced Bionics and Phonak by featuring a full performance package, including 100% wireless connectivity to consumer electronics and Binaural VoiceStream Technology for the best in bilateral and bimodal hearing. Further demonstrating that these two innovation leaders are partners for better hearing, the new Roger technology will be available for use with Naída CI processors providing AB recipients with access to the new digital wireless standard from Phonak.
For further information about these new products, please refer to the trade press releases of the respective brands.
This Media Release contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonova’s control. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
Sonova Holding AG
Sonova Holding AG, headquartered in Staefa, Switzerland, is the leading manufacturer of innovative hearing care solutions. The group operates through its core business brands Phonak, Unitron, Advanced Bionics and Connect Hearing. Sonova offers its customers one of the most comprehensive product portfolios in the industry - from hearing instruments to cochlear implants to wireless communication solutions. Founded in 1947, the group is currently present in over 90 countries across the globe and has a workforce of almost 9,000 dedicated employees. Sonova generated sales of CHF 1.8 billion in the financial year 2012/13 and a normalized net profit of CHF 309 million. By supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.
For more information please visit www.sonova.com and www.hear-the-world.com.